What is the BRAVOTM Model?
Application Area includes but not limited to:
RISK STRATIFICATION
The BRAVO model can be linked to a health system/ insurance plan to conduct risk stratification in the covered people with diabetes. Each patient will be assigned to the corresponding risk strata based on their predicted short-term/long-term risks of cardiovascular diseases and mortality. Thus, the BRAVO model can help the health system/ insurance to maximize the effectiveness of diabetes management by pinpointing the high-risk population.
Trial Simulation
The BRAVO simulation model can extrapolate the short-term (e.g., six-month) efficacy trials to a long-term cardiovascular outcomes trial (CVOT). It can serve as the real-world extension of the existing trials to explore the long-term benefit of the corresponding treatments.
COST EFFECTIVENESS ANALYSIS
It can be applied to conduct classic pharmacoeconomics evaluation, comparing the cost-effectiveness between alternative drugs/treatments.
program evaluation
The BRAVO model can be used to evaluate the benefit and cost-effectiveness of a policy/program/guideline. We have applied the model to evaluate the Medicare PartD Senior Saving Mode, the ADA’s diabetes insight program, and the American College of Physicians’ guidance statement on glycemic control.
About BRAVO™ MODEL

bravo™ model compares to other diabetes models

BW and BMI

Hypoglycemia

GLOBALIZATION
